| September 13, 2012 |
John Hornberger MD MS, Cedar CEO & President, presented Reference-based Pricing: the Good, the Bad and the Ugly at the 4th Annual Personalized Medicine Conference in Boston, MA. |
| June 8, 2012 |
Accepted for publication: Clinical utility of gene-expression profiling for tumor-site origin in patients with metastatic or poorly differentiated cancer: impact on diagnosis, treatment, and survival |
| May 2, 2012 |
Accepted for publication in the Journal of the National Cancer Institute: Clinical Utility/Validity, Change in Practice Patterns, and Economic implications of Risk Stratifiers to Predict Outcomes for Early-Stage Breast Cancer: A Systematic Review |
| March 20, 2012 |
Cedar Associates research cited in U.S. Supreme Court personalized medicine patent decision |
| February 2, 2012 |
Accepted for publication in Genetic Testing and Molecular Biomarkers: Laboratory-Developed Test—SynFRAME: An Approach for Assessing Laboratory-Developed Tests Synthesized
from Prior Appraisal Frameworks
|
| March 29, 2011 |
Accepted for publication: Clinical utility of gene-expression profiling for tumor site origin |
| January 27, 2011 |
Novel Gene Test Effective in Identifying Primary Tumor Sites |
| November 3, 2009 |
Accepted for publication: Economic implications of 21-gene breast cancer risk assay from the perspective of an Israeli-managed health-care organization. |
| June 26, 2009 |
American Health Care Reform – Making Progress?
Policy analysis by John Hornberger, MD, MS |
| May 5, 2009 |
Molecular Diagnostics cites Cedar's economic analysis of Genomic Health's Oncotype DX as a valuable and compelling argument which justifies premium pricing of the assay to payors |
| April 23, 2009 |
Accepted for publication: Cedar manuscript proposes pragmatic solutions to antiretroviral treatment barriers in resource-limited settings |
| April 10, 2009 |
John Hornberger to present a session on “Pharmacoeconomics, Cost Effectiveness, and Outcome Analysis for Personalized Medicine” |
| February 18, 2009 |
Poster Accepted for Presentation at Digestive Disease Week |
| February 9, 2009 |
H.R. 6331: Medicare Improvements for Patients and Providers Act of 2008 |
